Carcinoma (n = 37) | Mutation Events | Frequency | |
---|---|---|---|
KRAS | 24 | 64.9 | |
TP53 | 24 | * | 56.8 |
CDKN2A | 8 | * | 18.9 |
PIK3CA | 5 | 13.5 | |
PTEN | 2 | * | 2.7 |
BRAF | 2 | 5.4 | |
FGFR2 | 1 | 2.7 | |
STK11 | 1 | 2.7 | |
CTNNB1 | 2 | 5.4 | |
SRC | 1 | 2.7 | |
SMAD4 | 1 | 2.7 | |
Total Number Mutations | 71 | ||
ERBB2 Amplification | 14 | § | 37.8 |
Borderline Tumor (n = 26) | Mutation Events | Frequency | |
KRAS | 24 | 92.3 | |
TP53 | 3 | 11.5 | |
CDKN2A | 5 | 19.2 | |
PIK3CA | 4 | 15.4 | |
PTEN | 1 | 3.8 | |
GNA11 | 1 | 3.8 | |
ERBB2 | 1 | 3.8 | |
Total Number Mutations | 39 | ||
ERBB2 Amplification | 3 | § | 11.5 |
Total # Mutations | 110 |